In this issue, we have covered a couple of hot topics that are currently trending in the biotech and blockchain technology industries. We have highlighted Illumina’s Q2 results and provided some
insights about the company alongwith a quick run-through of the firm's recent collaborations in China. Illumina reported a revenue of $830 million in Q2 which is a 25% increase compared to $662 million in the same quarter of 2017. Illumina’s biggest advantage over its competitors lies in its technology diversification.
Category: blockchain
2018 / Analytics / blockchain / China / Illumina / Landscape Analysis / Landscape Reports / Newsletters / Patent / patent search / Reports / Walmart